Description
The purpose of this Notice of Amendment is to notify about the additions of Dequalinium chloride, Enfortumab vedotin, Somatrogon, and Tralokinumab to the Prescription Drug List (PDL) for human and veterinary use.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice: Prescription Drug List (PDL): Multiple Additions (2021-11-15) | HTML | Open resource | |
| Notice: Prescription Drug List (PDL): Multiple Additions (2021-11-15) | HTML | Open resource |